Epstein Secrets

self will be going to the scene for an Investigation. Note Type: General Department: Communications Date7Tme: 08/10/2019 09:29 Entered By: Notes: Geraldine from Uve On NY requested a hold accenting to Director of MU unable to give them one because of this case being high profile. Note Type: Department:

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

o the scene for an investigation. Note Type: General Department: Communications Datertnte: 0&10/20190929 Entered By: Sandra Sykes-Manikie Notes: Geraldine from Live On NY requested a hold according to Director of MU unable to give them one because of this case being high profile. Note Type: Department

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

rson. s e Investigations/Operations about this case. Note Type: General Department Communications MISTS,: 0810/2019 09:29 Entered By. Notes: Geraldine from Live On NY requested a hold according to Director of MU unable to give them one because of this case being high profit,. Note Type: Departmen

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n